NPPA slaps Rs 4.92 crore demand notice on Natco Pharma for overcharging 
Corporate Watch

NPPA slaps Rs 4.92 crore demand notice on Natco Pharma for overcharging

Natco Pharma Ltd on Thursday said it has received a demand notice of over Rs 4.92 crore from NPPA for alleged overcharging for two drugs

PTI

New Delhi: Natco Pharma Ltd on Thursday said it has received a demand notice of over Rs 4.92 crore from the National Pharmaceutical Pricing Authority (NPPA) for alleged overcharging for two drugs.

Follow The PSUWatch Channel on WhatsApp

The National Pharmaceutical Pricing Authority (NPPA) has issued demand notice "under para 15 of Drugs Price Control Order, 2013 directing the company to deposit an amount of Rs 4,92,25,923, including overcharge amount, penalty and interest", Natco Pharma said in a regulatory filing.

Follow PSU Watch on LinkedIN

The demand notice alleges overcharging for two drugs covering the period between April 2023 and November 2023, it added.

There is no material impact on financial, operational and other activities of the company, it added.

(PSU Watch– India's Business News centre that places the spotlight on PSUs, Bureaucracy, Defence and Public Policy is now on Google News. Click here to follow. Also, join PSU Watch Channel in your Telegram. You may also follow us on Twitter here and stay updated.)

India’s crude import bill for April-October nears full-year 2025-26 total

DTC plans to tie up with Indian Oil to set up petrol pumps at its bus depots

SEBI proposes tighter tenure limits for MDs, lower age cap for public interest directors at MIIs

NITI Aayog bats for land acquisition in advance for future projects in Maharashtra

CAG launches multi-year audit of 101 cities to assess urban reforms